Construction of eukaryotic expression vector of recombinant immunotoxin human VEGF165-PE38 and its expression
10.3760/cma.j.issn.1006-9801.2009.04.003
- VernacularTitle:VEGF165-PE38重组免疫毒素真核表达载体的构建及表达
- Author:
Changchen HU
;
Yiquan KE
;
Binquan WANG
;
Liyuan ZHOU
;
Jun Lü
;
Fabing ZHANG
;
Jiankan LU
;
Yingqian CAI
;
Lingsha QIN
- Publication Type:Journal Article
- Keywords:
Vascular endothelial growth factor;
PE38;
Recombinant;
Immunotoxin;
HEK293 cells;
Eukaryotic expression
- From:
Cancer Research and Clinic
2009;21(4):222-225
- CountryChina
- Language:Chinese
-
Abstract:
Objective To construct a new recombinant immunotoxin expression vector by using human VEGF165 and a truncated pseudomonas exotoxin A ramification (PE38) gene, and explore the expression of the VEGF165-PE38 fusion protein in HEK293 cells. Methods VEGF165 was cloned by polymerase chain reaction (PCR). PE38 gene was gained from an vector plasmid pRB391 by restriction endonuclease digestion, and then inserted to the eukaryotic expression vector pIRES2-EGFP. After the eukaryotic recombinant vector pIRES2-VEGF165-PE38-EGFP was identified by restriction endonuclease digestion and sequence analysis, the vector was transfected into HEK293 cells by liposome protocol. RT-PCR and ELISA method was used to confirm the expression of the fusion gene in the HEK293 cells. Results Restriction endonuclease digestion and sequence analysis revealed the VEGF165-PE38 fusion gene was cloned into the eukaryotic expression plasmid vector pIRES2-EGFP successfully. The pIRES2-VEGF165-PE38-EGFP fusion gene could express in the HEK293 cells. Conclusion The result provide the basis for search of the targeted cytotoxic activity to tumor vascular endothelial cells and may have some potential value in clinical application.
